Nociscan Selected for Inclusion in Pivotal National Institutes of Health (NIH) Study for Low Back Pain

NIH funded Biomarkers for Evaluating Spine Treatments (BEST) Trial launching this quarter

BEST to study the role of biomarkers in optimizing the treatment of chronic low back pain

NociscanTM to be commercially active across seven participating major academic medical centers